`
`“—
`
`——
`
`
`
`——
`——
`
`Title of Invention:
`
`Buprenorphine-Wafer for Drug Substitution Therapy
`
`Payment information:
`
`yes—
`Submitted with Payment
`
`he Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`——
`
`— T
`
`
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Miscellaneous Incoming Letter
`
`1861_2700001_Cover1.pdf
`
`Oath or Declaration filed
`
`1861_2700001_Dec1.pdf
`
`190313
`
`0846d767dbdfbb86c8a6de4ce5709579843
`0d204
`
`200633
`
`e8e547f47dbaa0eb99a56c06336:3109a01
`154da
`
`File Listing:
`
`Document
`
`Information:
`
`Information:
`
`Information:
`
`Information:
`
`9056
`
`Amend ment/Req. Reconsideration-After
`Non_Fina| Reject
`
`1861_27000O1_Rep|y.pdf
`
`df36a818571216fl0972efa479c20676d666
`dbaO
`
`142655
`
`Terminal Disclaimer Filed
`
`1861_2700001_TD.pdf
`
`160909
`
`dc8f06c0c52e2691d63cc3847170b522638
`da379
`
`Fee Worksheet (SBO6)
`
`fee-info.pdf
`
`4f027fe31fd19369bbadce98d4ccf1d23b28
`
`
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`the application.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`
`